Found: 20
Select item for more details and to access through your institution.
Molecular imaging and fluid biomarkers of Alzheimer's disease neuropathology: an opportunity for integrated diagnostics.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
The strategic biomarker roadmap for the validation of Alzheimer's diagnostic biomarkers: methodological update.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 7, p. 2070, doi. 10.1007/s00259-020-05120-2
- By:
- Publication type:
- Article
Clinical validity of increased cortical binding of tau ligands of the THK family and PBB3 on PET as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 7, p. 2086, doi. 10.1007/s00259-021-05277-4
- By:
- Publication type:
- Article
Clinical validity of increased cortical uptake of [18F]flortaucipir on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase biomarker development framework.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 7, p. 2097, doi. 10.1007/s00259-020-05118-w
- By:
- Publication type:
- Article
Clinical validity of second-generation tau PET tracers as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 7, p. 2110, doi. 10.1007/s00259-020-05156-4
- By:
- Publication type:
- Article
2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 7, p. 2121, doi. 10.1007/s00259-021-05258-7
- By:
- Publication type:
- Article
The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 7, p. 2140, doi. 10.1007/s00259-021-05253-y
- By:
- Publication type:
- Article
Outcomes of clinical utility in amyloid-PET studies: state of art and future perspectives.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 7, p. 2157, doi. 10.1007/s00259-020-05187-x
- By:
- Publication type:
- Article
Visual assessment of [18F]flutemetamol PET images can detect early amyloid pathology and grade its extent.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 7, p. 2169, doi. 10.1007/s00259-020-05174-2
- By:
- Publication type:
- Article
A multisite analysis of the concordance between visual image interpretation and quantitative analysis of [18F]flutemetamol amyloid PET images.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 7, p. 2183, doi. 10.1007/s00259-021-05311-5
- By:
- Publication type:
- Article
Diagnostic value of amyloid-PET and tau-PET: a head-to-head comparison.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 7, p. 2200, doi. 10.1007/s00259-021-05246-x
- By:
- Publication type:
- Article
Differential associations of APOE-ε2 and APOE-ε4 alleles with PET-measured amyloid-β and tau deposition in older individuals without dementia.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 7, p. 2212, doi. 10.1007/s00259-021-05192-8
- By:
- Publication type:
- Article
Relationship between amyloid and tau levels and its impact on tau spreading.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 7, p. 2225, doi. 10.1007/s00259-021-05191-9
- By:
- Publication type:
- Article
Tau PET imaging with 18F-PI-2620 in aging and neurodegenerative diseases.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 7, p. 2233, doi. 10.1007/s00259-020-04923-7
- By:
- Publication type:
- Article
The impact of demographic, clinical, genetic, and imaging variables on tau PET status.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 7, p. 2245, doi. 10.1007/s00259-020-05099-w
- By:
- Publication type:
- Article
Comparing ATN-T designation by tau PET visual reads, tau PET quantification, and CSF PTau181 across three cohorts.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 7, p. 2259, doi. 10.1007/s00259-020-05152-8
- By:
- Publication type:
- Article
Indication of retrograde tau spreading along Braak stages and functional connectivity pathways.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 7, p. 2272, doi. 10.1007/s00259-020-05183-1
- By:
- Publication type:
- Article
Reduced [18F]flortaucipir retention in white matter hyperintensities compared to normal-appearing white matter.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 7, p. 2283, doi. 10.1007/s00259-021-05195-5
- By:
- Publication type:
- Article
A multicenter comparison of [18F]flortaucipir, [18F]RO948, and [18F]MK6240 tau PET tracers to detect a common target ROI for differential diagnosis.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 7, p. 2295, doi. 10.1007/s00259-021-05401-4
- By:
- Publication type:
- Article
Oxford-AstraZeneca COVID-19 vaccination induced lymphadenopathy on [18F]Choline PET/CT—not only an FDG finding.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 7, p. 2657, doi. 10.1007/s00259-021-05274-7
- By:
- Publication type:
- Article